People / Staff

Manuel Vázquez Carrera

Search publications

Publications

  • Coll T, Rodrïguez-Calvo R, Barroso E, Serrano L, Eyre E, Palomer FX and Vazquez M.

    Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.

    Current Molecular Pharmacology . 2(1): 46-55.

  • Pou J, Rebollo A, Roglans N, Sánchez RM, Vazquez M, Laguna JC, Pedro-Botet J and Alegret M.

    Ritonavir increases CD36, ABCA1 and CYP27 expression in THP-1 macrophages.

    EXPERIMENTAL BIOLOGY AND MEDICINE . 233(12): 1572-1582. Number of citations: 10

    [doi:10.3181/0805-RM-144]

  • Vilà L, Roglans N, Alegret M, Sánchez RM, Vazquez M and Laguna JC.

    Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism.

    HEPATOLOGY . 48(5): 1506-1516. Number of citations: 75

    [doi:10.1002/hep.22523]

  • Vilà L, Roglans N, Alegret M, Camins A, Pallàs M, Sánchez RM, Vazquez M and Laguna JC.

    Hepatic gene expression changes in an experimental model of accelerated senescence: the SAM-P8 mouse.

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES . 63(10): 1043-1052. Number of citations: 3

    [doi:10.1093/gerona/63.10.1043]

  • Rodríguez-Calvo R, Serrano L, Coll T, Moullan N, Sánchez RM, Merlos M, Palomer FX, Laguna JC, Michalik L, Wahli W and Vazquez M.

    Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.

    Diabetes . 57(8): 2149-2157. Number of citations: 101

    [doi:10.2337/db08-0176]

  • Llaverias G, Pou J, Ros E, Zambón D, Cofán M, Sánchez A, Vazquez M, Sánchez RM, Laguna JC and Alegret M.

    Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment.

    Pharmacogenomics . 9(8): 1035-1054. Number of citations: 13

    [doi:10.2217/14622416.9.8.1035]

  • Coll T, Eyre E, Rodríguez-Calvo R, Palomer FX, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells.

    JOURNAL OF BIOLOGICAL CHEMISTRY . 283(17): 11107-11116. Number of citations: 281

    [doi:10.1074/jbc.M708700200]

  • Planavila A, Rodríguez-Calvo R, Palomer FX, Coll T, Sánchez RM, Merlos M, Laguna JC and Vazquez M.

    Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1781(1-2): 26-35. Number of citations: 15

    [doi:10.1016/j.bbalip.2007.10.009]

  • Rodríguez-Calvo R, Serrano L, Barroso E, Coll T, Palomer FX, Camins A, Sánchez RM, Alegret M, Merlos M, Pallàs M, Laguna JC and Vazquez M.

    Peroxisome proliferator-activated receptor alpha down-regulation is associated with enhanced ceramide levels in age-associated cardiac hypertrophy.

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES . 62(12): 1326-1336. Number of citations: 22

    [doi:10.1093/gerona/62.12.1326]

  • Vilà L, Roglans N, Alegret M, Camins A, Pallàs M, Sánchez RM, Vazquez M and Laguna JC.

    Hypertriglyceridemia and hepatic steatosis in senescence-accelerated mouse associate to changes in lipid-related gene expression.

    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES . 62(11): 1219-1227. Number of citations: 13

    [doi:10.1093/gerona/62.11.1219]